𝔖 Bobbio Scriptorium
✦   LIBER   ✦

ERBB3/HER3 and ERBB2/HER2 Duet in Mammary Development and Breast Cancer

✍ Scribed by David F. Stern

Publisher
Springer US
Year
2008
Tongue
English
Weight
180 KB
Volume
13
Category
Article
ISSN
1083-3021

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Downregulation of erbB3 abrogates erbB2-
Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cells
✍ Bolin Liu; Dalia Ordonez-Ercan; Zeying Fan; Susan M. Edgerton; XiaoHe Yang; Ann πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 654 KB

## Abstract Receptor tyrosine kinase activity is essential for erbB2 (HER2/__neu__) promotion of breast carcinogenesis, metastasis and therapeutic resistance. erbB2 kinase can be activated by dimerization with another erbB receptor, most of which bind ligands. Of these, the erbB2/erbB3 heterodimer

c-erbB-2 (HER-2/neu) protein and drug re
c-erbB-2 (HER-2/neu) protein and drug resistance in breast cancer patients treated with induction chemotherapy
✍ Laura M. Vargas-Roig; Francisco E. Gago; Olga Tello; MarΓ­a T. Martin de Civetta; πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 71 KB πŸ‘ 2 views

Expression of c-erbB-2 protein has been associated with poor prognosis and poor response to chemotherapy in breast cancer patients. In the present prospective study, we have analyzed whether c-erbB-2, p53 and P170 proteins may be determinants of tumor resistance in locally advanced breast cancer pat